Kelman A - Search Results

1

Pregnancy outcomes after maternal exposure to rituximab.

Chakravarty EF, Murray ER, Kelman A, Farmer P. Chakravarty EF, et al. Among authors: kelman a. Blood. 2011 Feb 3;117(5):1499-506. doi: 10.1182/blood-2010-07-295444. Epub 2010 Nov 23. Blood. 2011. PMID: 21098742 Free article.

2

A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands.

Magnano MD, Chakravarty EF, Broudy C, Chung L, Kelman A, Hillygus J, Genovese MC. Magnano MD, et al. Among authors: kelman a. J Rheumatol. 2007 Jun;34(6):1323-7. Epub 2007 May 15. J Rheumatol. 2007. PMID: 17516620 Clinical Trial.

3

Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A. Bingham CO 3rd, et al. Among authors: kelman a. Arthritis Rheum. 2010 Jan;62(1):64-74. doi: 10.1002/art.25034. Arthritis Rheum. 2010. PMID: 20039397 Free article. Clinical Trial.

4

Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials.

van Vollenhoven RF, Emery P, Bingham CO 3rd, Keystone EC, Fleischmann R, Furst DE, Macey K, Sweetser M, Kelman A, Rao R. van Vollenhoven RF, et al. Among authors: kelman a. J Rheumatol. 2010 Mar;37(3):558-67. doi: 10.3899/jrheum.090856. Epub 2010 Jan 28. J Rheumatol. 2010. PMID: 20110520 Free article.

5

Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trial.

Mease PJ, Cohen S, Gaylis NB, Chubick A, Kaell AT, Greenwald M, Agarwal S, Yin M, Kelman A. Mease PJ, et al. Among authors: kelman a. J Rheumatol. 2010 May;37(5):917-27. doi: 10.3899/jrheum.090442. Epub 2010 Mar 1. J Rheumatol. 2010. PMID: 20194448 Clinical Trial.

6

A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis.

Owczarczyk K, Lal P, Abbas AR, Wolslegel K, Holweg CT, Dummer W, Kelman A, Brunetta P, Lewin-Koh N, Sorani M, Leong D, Fielder P, Yocum D, Ho C, Ortmann W, Townsend MJ, Behrens TW. Owczarczyk K, et al. Among authors: kelman a. Sci Transl Med. 2011 Sep 21;3(101):101ra92. doi: 10.1126/scitranslmed.3002432. Sci Transl Med. 2011. PMID: 21937757

7

Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.

Lal P, Su Z, Holweg CT, Silverman GJ, Schwartzman S, Kelman A, Read S, Spaniolo G, Monroe JG, Behrens TW, Townsend MJ. Lal P, et al. Among authors: kelman a. Arthritis Rheum. 2011 Dec;63(12):3681-91. doi: 10.1002/art.30596. Arthritis Rheum. 2011. PMID: 22127691 Free article. Clinical Trial.

8

Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.

Genovese MC, Kremer JM, van Vollenhoven RF, Alten R, Scali JJ, Kelman A, Dimonaco S, Brockwell L. Genovese MC, et al. Among authors: kelman a. Arthritis Rheumatol. 2017 Sep;69(9):1751-1761. doi: 10.1002/art.40176. Epub 2017 Aug 1. Arthritis Rheumatol. 2017. PMID: 28597609

9

The management of secondary osteoporosis.

Kelman A, Lane NE. Kelman A, et al. Best Pract Res Clin Rheumatol. 2005 Dec;19(6):1021-37. doi: 10.1016/j.berh.2005.06.005. Best Pract Res Clin Rheumatol. 2005. PMID: 16301195 Review.

10

Outcome measures in osteoarthritis: randomized controlled trials.

Strand V, Kelman A. Strand V, et al. Among authors: kelman a. Curr Rheumatol Rep. 2004 Feb;6(1):20-30. doi: 10.1007/s11926-004-0080-6. Curr Rheumatol Rep. 2004. PMID: 14713399 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page